PT  - JOURNAL ARTICLE
AU  - Durstenfeld, Matthew S.
AU  - Wilson, Melissa P.
AU  - Jankowski, Catherine M.
AU  - Ditzenberger, Grace L.
AU  - Longenecker, Chris T.
AU  - Erlandson, Kristine M.
TI  - Chronotropic Incompetence among People with HIV Improves with Exercise Training in the Exercise for Healthy Aging Study
AID  - 10.1101/2023.11.10.23298367
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.10.23298367
4099  - http://medrxiv.org/content/early/2023/11/10/2023.11.10.23298367.short
4100  - http://medrxiv.org/content/early/2023/11/10/2023.11.10.23298367.full
AB  - Background People with HIV (PWH) have lower exercise capacity compared to HIV uninfected peers, which may be explained by chronotropic incompetence (CI), the inability to increase heart rate during exercise.Methods The Exercise for Healthy Aging Study included adults ages 50-75 with and without HIV. Participants completed 12 weeks of moderate intensity exercise, before randomization to moderate or high intensity for 12 additional weeks. We compared adjusted heart rate reserve (AHRR; CI <80%) on cardiopulmonary exercise testing by HIV serostatus, and change from baseline to 12 and 24 weeks using mixed effects models.Results Among 32 PWH and 37 controls (median age 56, 7% female, mean BMI 28 kg/m2), 28% of PWH compared to 11% of controls had CI at baseline (p=0.067). AHRR was lower among PWH (91 vs 102%; difference 11%, 95% CI 2.5-19.7; p=0.01). At week 12, AHRR normalized among PWH (+8%, 95% CI 4-11; p<0.001) and was sustained at week 24 (+5, 95%CI 1-9; p=0.008) compared to no change among controls (95%CI –4 to 4; p=0.95; pinteraction=0.004). After 24 weeks of exercise, only 15% PWH and 10% of controls had CI (p=0.70).Conclusions Chronotropic incompetence contributes to reduced exercise capacity among PWH and improves with exercise training.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02404792Funding StatementThis study was funded by the National Institute on Aging to Dr. Erlandson (K23 AG050260 and K24AG082527). Dr. Durstenfeld is funded by NIH grant NIH/NLBI (K12 HL143961).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The original study was approved by the Colorado Multiple Institution Review Board and written informed consent was obtained.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData is available upon reasonable request to the authors.